Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 17, 2023
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
[ Wed, May 17th 2023
] - WOPRAI
Tue, May 16, 2023
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
Gregory Renza Reiterated (SPRB) at Buy and Held Target at $8 on, May 16th, 2023
Gregory Renza of RBC Capital, Reiterated "Spruce Biosciences, Inc." (SPRB) at Buy and Held Target at $8 on, May 16th, 2023.
Gregory has made no other calls on SPRB in the last 4 months.
There is 1 other peer that has a rating on SPRB. Out of the 1 peers that are also analyzing SPRB, 0 agree with Gregory's Rating of Hold.
This is the rating of the analyst that currently disagrees with Gregory
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $10 on, Thursday, March 23rd, 2023
